Marc Ladanyi Named to Endowed Chair

on Saturday, January 1, 2011

Marc Ladanyi
Summary

Marc Ladanyi has been named the incumbent of the newly endowed William Ruane Chair in Molecular Oncology.

Marc Ladanyi has been named the incumbent of the newly endowed William Ruane Chair in Molecular Oncology. The chair was made possible by a gift from the late William J. Ruane, a longtime supporter of Memorial Sloan Kettering.

Dr. Ladanyi is Attending Pathologist in Molecular Diagnostics Service of the Department of Pathology and Member in the Human Oncology and Pathogenesis Program. He is a molecular pathologist whose laboratory works on the genomics and molecular pathogenesis of sarcomas and thoracic malignancies. He also co-directs The Cancer Genome Atlas (TCGA) group at Memorial Sloan Kettering, part of the National Cancer Institute’s TCGA project network. He has authored or co-authored more than 195 primary research papers and more than 40 reviews and commentaries.

A noted investigator, Dr. Ladanyi has received Young Investigator Awards from the US and Canadian Academy of Pathology and from Memorial Sloan Kettering. In 2007 he was awarded the Nina Axelrod Lectureship by the Connective Tissue Oncology Society, and in 2009 received the Caine Halter Hope Now Award from Uniting Against Lung Cancer.

 

Add new comment

We welcome your questions and comments. While we share many of them with our world-class doctors and researchers, we regret that in order to protect your privacy, we are not able to make personal medical recommendations on this forum, nor do we publish comments that contain your personal information. If you would like to consult with an MSK doctor, we encourage you to make an appointment at 800-525-2225 or request an appointment online.

Your email address is kept private and will not be shown publicly.